Dear Patients and Families,
Being diagnosed with unresectable or metastatic melanoma carrying a BRAF V600E or BRAF V600K mutation is never easy. It marks the beginning of a journey filled with questions, emotions, and choices. We understand that this moment brings more than just a medical challenge—it brings fear, uncertainty, and the need for strength you may not have known you possessed.
At Lucius Pharmaceuticals, we see you—not just the diagnosis, but the person behind it. Every therapy we develop has one goal: to help you fight with more clarity, more control, and more hope.
Why We Do What We Do
Our mission is rooted in science, but our purpose is human.
We developed targeted therapies like dabrafenib, trametinib, Encorafenib and vemurafenib to interrupt the specific mutations that drive cancer growth. These medicines are designed for people like you—patients whose cancers are linked to specific genetic mutations.
Clinical experience and patient reports have shown that these therapies may help manage disease progression, alleviate certain symptoms, and improve quality of life for some individuals. While outcomes vary, many patients have been able to maintain meaningful daily routines and spend valuable time with loved ones during treatment.
These moments remind us why our work matters.
We Know It’s Not Just About the Medicine
Treatment comes with its own burdens—side effects, emotional fatigue, the need to make difficult decisions. We know that some days may feel heavy. But you are not alone.
Lucius Pharmaceuticals is committed not only to developing effective medicines, but also to supporting you at every step. We provide patient education, collaborate closely with healthcare professionals, and advocate for access to care—because treatment is not just about a pill; it’s about your journey.
You Inspire Us
Your determination gives meaning to every hour we spend in the lab.
Every scan that shows progress… every extra day gained… is why we exist.
Looking Ahead — With You
Medical science is constantly evolving, and so are we. At Lucius Pharmaceuticals, our research continues—toward new therapies, smarter combinations, and better outcomes for all patients living with advanced melanoma.
To those who are still in treatment, and to the loved ones who walk beside them: thank you for your courage. Thank you for trusting our science. Thank you for reminding us, every day, that medicine is not about molecules—it’s about people.
We walk this path with you.
— Lucius Pharmaceuticals Team
